These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Is there a relationship in pathogenesis between arteriosclerosis and familial hypercholesteremia? THANNHAUSER SJ Bull New Engl Med Cent; 1950 Aug; 12(4):129-33. PubMed ID: 15434572 [No Abstract] [Full Text] [Related]
10. ESSENTIAL FAMILIAL HYPERCHOLESTEROLEMIA AND XANTHOMATOUS HEART DISEASE. SANCHEZ-VALENTIN R; GARCIA-PALMIERI MR Bol Asoc Med P R; 1963 Sep; 55():359-71. PubMed ID: 14051425 [No Abstract] [Full Text] [Related]
11. THE OCULAR MANIFESTATIONS OF EXPERIMENTAL HYPERCHOLESTERAEMIA IN RABBITS. FRANCOIS J; NEETENS A Ophthalmologica; 1964; 148():57-79. PubMed ID: 14185134 [No Abstract] [Full Text] [Related]
12. ASTEROID HYALITIS: RELATIONSHIP TO DIABETES AND HYPERCHOLESTEROLEMIA. BARD LA Am J Ophthalmol; 1964 Aug; 58():239-42. PubMed ID: 14202509 [No Abstract] [Full Text] [Related]
13. [Familial essential hypercholesteremia and xanthomatosis; katamnestic and continued studies of 12 Danish families]. PIPER J; ORRILD L Ugeskr Laeger; 1955 Oct; 117(43):1397-405. PubMed ID: 13281958 [No Abstract] [Full Text] [Related]
14. [FAMILIAL XANTHOMATOUS HYPERCHOLESTEREMIA]. FAIVRE G; GILGENKRANTZ JM; CHERRIER F; HENRY C Coeur Med Interne; 1963 Oct; 58():405-11. PubMed ID: 14092610 [No Abstract] [Full Text] [Related]
15. [ON XANTHOMATOSIS CAUSED BY ESSENTIAL HYPERCHOLESTEROLEMIA]. PISANI M; BIONDI C; DELUCA M Minerva Dermatol; 1964 Jun; 39():159-66. PubMed ID: 14178499 [No Abstract] [Full Text] [Related]
16. [FAMILIAL XANTHOMATOUS HYPERCHOLESTEROLEMIA. BIOCLINICAL AND THERAPEUTIC STUDY]. LEURIDAN B J Sci Med Lille; 1965 Feb; 83():137-8. PubMed ID: 14308373 [No Abstract] [Full Text] [Related]
17. Current practices in general medicine. 11. Essential hypercholesteremia and its management. JUERGENS JL; ACHOR RW Proc Staff Meet Mayo Clin; 1959 Nov; 34():533-42. PubMed ID: 14408093 [No Abstract] [Full Text] [Related]
18. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia. Geiss HC; Schwandt P; Parhofer KG Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):182-7. PubMed ID: 12058342 [TBL] [Abstract][Full Text] [Related]
19. Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin. Homma K; Homma Y; Yoshida T; Ozawa H; Shiina Y; Wakino S; Hayashi K; Itoh H; Hori S J Clin Lipidol; 2015; 9(2):210-6. PubMed ID: 25911077 [TBL] [Abstract][Full Text] [Related]
20. Ocular changes in experimental hypercholesteremia. COGAN DG; KUWABARA T AMA Arch Ophthalmol; 1959 Feb; 61(2):219-25. PubMed ID: 13616784 [No Abstract] [Full Text] [Related] [Next] [New Search]